• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-糖蛋白不能保护细胞免受成孔蛋白诱导的细胞溶解作用。

P-glycoprotein does not protect cells against cytolysis induced by pore-forming proteins.

作者信息

Johnstone R W, Tainton K M, Ruefli A A, Froelich C J, Cerruti L, Jane S M, Smyth M J

机构信息

Peter MacCallum Cancer Institute, Trescowthick Research Laboratories, St. Andrews Place, East Melbourne 3002, Victoria, Australia.

出版信息

J Biol Chem. 2001 May 18;276(20):16667-73. doi: 10.1074/jbc.M010774200. Epub 2001 Feb 20.

DOI:10.1074/jbc.M010774200
PMID:11278745
Abstract

P-glycoprotein (P-gp) is an ATP-dependent drug pump that confers multidrug resistance (MDR). In addition to its ability to efflux toxins, P-gp can also inhibit apoptosis induced by a wide array of cell death stimuli that rely on activation of intracellular caspases for full function. We therefore hypothesized that P-gp may have additional functions in addition to its role in effluxing xenotoxins that could provide protection to tumor cells against a host response. There have been a number of contradictory reports concerning the role of P-gp in regulating complement activation. Given the disparate results obtained by different laboratories and our published results demonstrating that P-gp does not affect cell death induced by another membranolytic protein, perforin, we decided to assess the role of P-gp in regulating cell lysis induced by a number of different pore-forming proteins. Testing a variety of different P-gp-expressing MDR cell lines produced following exposure of cells to chemotherapeutic agents or by retroviral gene transduction in the complete absence of any drug selection, we found no difference in sensitivity of P-gp(+ve) or P-gp(-ve) cells to the pore-forming proteins complement, perforin, or pneumolysin. Based on these results, we conclude that P-gp does not affect cell lysis induced by pore-forming proteins.

摘要

P-糖蛋白(P-gp)是一种依赖ATP的药物泵,可赋予多药耐药性(MDR)。除了具有排出毒素的能力外,P-gp还能抑制由多种细胞死亡刺激诱导的凋亡,这些刺激依赖细胞内半胱天冬酶的激活来发挥全部功能。因此,我们推测P-gp除了在排出外源性毒素方面发挥作用外,可能还具有其他功能,从而为肿瘤细胞提供针对宿主反应的保护。关于P-gp在调节补体激活中的作用,已有许多相互矛盾的报道。鉴于不同实验室得到的结果存在差异,以及我们已发表的结果表明P-gp不影响另一种膜溶解蛋白穿孔素诱导的细胞死亡,我们决定评估P-gp在调节多种不同成孔蛋白诱导的细胞裂解中的作用。我们测试了多种不同的表达P-gp的多药耐药细胞系,这些细胞系是在细胞暴露于化疗药物后产生的,或者是通过逆转录病毒基因转导产生的,且完全没有任何药物选择,我们发现P-gp(阳性)或P-gp(阴性)细胞对成孔蛋白补体、穿孔素或肺炎链球菌溶血素的敏感性没有差异。基于这些结果,我们得出结论,P-gp不影响成孔蛋白诱导的细胞裂解。

相似文献

1
P-glycoprotein does not protect cells against cytolysis induced by pore-forming proteins.P-糖蛋白不能保护细胞免受成孔蛋白诱导的细胞溶解作用。
J Biol Chem. 2001 May 18;276(20):16667-73. doi: 10.1074/jbc.M010774200. Epub 2001 Feb 20.
2
P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death.P-糖蛋白可保护白血病细胞免受依赖半胱天冬酶的细胞死亡影响,但不能保护其免受非依赖半胱天冬酶的细胞死亡影响。
Blood. 1999 Feb 1;93(3):1075-85.
3
The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.药物外排蛋白P-糖蛋白还能保护耐药肿瘤细胞免受多种形式的半胱天冬酶依赖性凋亡。
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7024-9. doi: 10.1073/pnas.95.12.7024.
4
Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells.辛二酰苯胺异羟肟酸(SAHA)可克服多药耐药性,并诱导表达P-糖蛋白的细胞发生细胞死亡。
Int J Cancer. 2002 May 10;99(2):292-8. doi: 10.1002/ijc.10327.
5
Intracellular pH and multidrug resistance regulate complement-mediated cytotoxicity of nucleated human cells.
J Biol Chem. 1999 Apr 16;274(16):10877-88. doi: 10.1074/jbc.274.16.10877.
6
HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance.六亚甲基双乙酰胺可诱导一种不依赖半胱天冬酶的细胞死亡途径的激活,以克服P-糖蛋白介导的多药耐药性。
Blood. 2000 Apr 1;95(7):2378-85.
7
Rituximab but not other anti-CD20 antibodies reverses multidrug resistance in 2 B lymphoma cell lines, blocks the activity of P-glycoprotein (P-gp), and induces P-gp to translocate out of lipid rafts.利妥昔单抗而非其他抗CD20抗体可逆转两种B淋巴瘤细胞系中的多药耐药性,阻断P-糖蛋白(P-gp)的活性,并诱导P-gp从脂筏中转运出来。
J Immunother. 2006 Sep-Oct;29(5):536-44. doi: 10.1097/01.cji.0000211307.05869.6c.
8
Equivalent death of P-glycoprotein expressing and nonexpressing cells induced by the protein kinase C inhibitor staurosporine.
Biochem Biophys Res Commun. 2000 Sep 16;276(1):231-7. doi: 10.1006/bbrc.2000.3459.
9
Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.P-糖蛋白(P-gp)、多药耐药相关蛋白(MRP)和肺耐药蛋白的序列基因表达:阿霉素耐药人K562细胞系中P-gp和MRP的功能活性
Anticancer Drugs. 2001 Mar;12(3):247-58. doi: 10.1097/00001813-200103000-00010.
10
Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.多药耐药K562亚系中MDR1 mRNA水平、耐药因子与吡柔比星经P-糖蛋白介导的外排效率之间的关系。
Can J Physiol Pharmacol. 2002 Nov;80(11):1054-63. doi: 10.1139/y02-132.

引用本文的文献

1
Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models.非瑟酮靶向 YB-1/RSK 轴,而不依赖于其对 ERK 信号的影响:来自体外和体内黑素瘤模型的见解。
Sci Rep. 2018 Oct 24;8(1):15726. doi: 10.1038/s41598-018-33879-w.
2
Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cells.在药物筛选出的表达P-糖蛋白的多药耐药卵巢癌细胞中增强的补体抗性。
Clin Exp Immunol. 2009 Feb;155(2):239-48. doi: 10.1111/j.1365-2249.2008.03817.x. Epub 2008 Nov 24.
3
Mechanisms of apoptosis are retained in cells with P glycoprotein-mediated drug resistance.
凋亡机制在具有P糖蛋白介导的耐药性的细胞中得以保留。
Dokl Biol Sci. 2006 Mar-Apr;407:187-91. doi: 10.1134/s0012496606020219.